Our previous research has shown that increased levels of CysLT1R (the high affinity receptor for LTD4) and decreased levels of CysLT2R (the high affinity receptor for LTC4) in patient tumor tissues are associated with poor prognosis for patients with CRC [9]. Here, CYSLTR1 is linked to neoplasm.